Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
MaskForce is a Wisconsin-based personal protective equipment company that emerged from a Milwaukee-area consortium organized during the COVID-19 pandemic to develop reusable respirator-style face masks for frontline workers. The group, led by Husco and involving manufacturers, healthcare organizations, first responders, and educational institutions, designed a reusable medical-grade mask with disposable filters. Its products were initially distributed under FDA Emergency Use Authorization for use by healthcare professionals, and the company later commercialized reusable facemask products for individuals and businesses. MaskForce appears to operate as a medical device/PPE business rather than a therapeutic biotech or pharmaceutical company, with its core focus on infection-control hardware rather than drug development.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on MaskForce.